Crosslinked compounds and methods of making and using thereof

Details Crosslinked compounds and methods of making and using thereof Crosslinked compounds and methods of making and using thereof

2011-04-19

2011-04-19

Lukton, David (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S021200, C530S350000, C530S353000, C530S354000, C530S356000, C530S402000, C530S345000

Reexamination Certificate

active

07928069

ABSTRACT:
Described herein are crosslinked compounds useful in numerous treatments. Described herein are methods of making crosslinked compounds via (1) die oxidative coupling of two or more thiol compounds or (2) by the reaction between at least one thiol compound with at least one thiol-reactive compound.

REFERENCES:
patent: 4501860 (1985-02-01), Campbell et al.
patent: 4507413 (1985-03-01), Thoma et al.
patent: 4582865 (1986-04-01), Balazs et al.
patent: 4644059 (1987-02-01), Gordon
patent: 4713448 (1987-12-01), Balazs et al.
patent: 4767745 (1988-08-01), Young et al.
patent: 4851121 (1989-07-01), Yakota et al.
patent: 4925945 (1990-05-01), Klein et al.
patent: 4970303 (1990-11-01), Reardan et al.
patent: 5135919 (1992-08-01), Folkman et al.
patent: 5290807 (1994-03-01), Folkman et al.
patent: 5443953 (1995-08-01), Hansen et al.
patent: 5504074 (1996-04-01), D'Amato et al.
patent: 5554754 (1996-09-01), Ravichandran et al.
patent: 5616568 (1997-04-01), Pouyani et al.
patent: 5635603 (1997-06-01), Hansen et al.
patent: 5639725 (1997-06-01), O'Reilly et al.
patent: 5652347 (1997-07-01), Pouyani et al.
patent: 5661143 (1997-08-01), D'Amato et al.
patent: 5698586 (1997-12-01), Kishimoto et al.
patent: 5733876 (1998-03-01), O'Reilly et al.
patent: 5762918 (1998-06-01), Thorpe
patent: 5792845 (1998-08-01), O'Reilly et al.
patent: 5837682 (1998-11-01), Folkman et al.
patent: 5854205 (1998-12-01), O'Reilly et al.
patent: 5854221 (1998-12-01), Cao et al.
patent: 5861372 (1999-01-01), Folkman et al.
patent: 5874417 (1999-02-01), Prestwich et al.
patent: 5885795 (1999-03-01), O'Reilly et al.
patent: 5892069 (1999-04-01), D'Amato et al.
patent: 5945403 (1999-08-01), Folkman et al.
patent: 6017954 (2000-01-01), Folkman et al.
patent: 6024688 (2000-02-01), Folkman et al.
patent: 6086865 (2000-07-01), Folkman et al.
patent: 6174861 (2001-01-01), O'Reilly et al.
patent: 6310039 (2001-10-01), Kratz
patent: 6649742 (2003-11-01), Better et al.
patent: 6664372 (2003-12-01), Janda et al.
patent: 6825269 (2004-11-01), Gottschall
patent: 2005/0176620 (2005-08-01), Prestwich et al.
patent: 2006/0205674 (2006-09-01), Satyam
patent: 2009/0105193 (2009-04-01), Prestwich et al.
patent: WO 96/33750 (1996-10-01), None
patent: WO 98/22114 (1998-05-01), None
patent: WO 00/16818 (2000-03-01), None
patent: WO 02/06373 (2002-01-01), None
patent: WO 02/41877 (2002-05-01), None
Zara, Jane J. (Analytical Biochemistry 194(1), 156-62, 1991).
Carlsson, Biochemical Journal 173, 723-37, 1978.
Shu, Biomacromolecules 3, 1304-1311, 2002.
Abstract of EP 0,339,264 (Nov. 1989).
Definition of “Viscosupplementation”, from The Free Dictionary [online], retrieved on Oct. 7, 2010, 1 page, http://medical-dictionary.thefreedictionary.com/viscosupplementation.
Wen, “Intra-articular hyaluronic acid injections for knee osteoarthritis”, American Family Physician Online Article, pp. 1-6 (2000) http://www.aafp.org/afp/20000801/565.html.
Agren et al., “Developmentally programmed expression of hyaluronan in human skin and its appendages”,J. Invest. Dermatol., 109:219-224 (1997).
Aigner et al., “Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester”,J. Biomed. Mater. Res., 42:172-181 (1998).
Anseth and Bryant, “The effects of scaffold thickness on tissue engineered cartilage in photocrosslinked poly(ethylene oxide) hydrogel”,Biomaterials22:619-626 (2001).
Anseth et al., “In situ forming degradable networks and their application in tissue engineering and drug delivery”,J. Control. Release, 78:199-209 (2002).
Arnold et al., “Evaluation of resorbable barriers for preventing surgical adhesions”,Ferl. Steril., 73:157-161 (2000).
Band, P.A., “Hyaluronan derivatives: Chemistry and clinical applications. In: Laurent TC, editor The chemistry, biology and medical applications of hyaluronan and its derivatives”, London: Portland Press, p. 33-42. (1998).
Barbucci et al., “Synthesis, chemical and theological characterization of new hyaluronic acid-based hydrogels”,Biomater. Sci. Polym. Ed., 11:383-99 (2000).
Belluco et al., “Prevention of postsurgical adhesions with an autocrosslinked hyaluronan derivative gel”,J. Surg. Res., 100:217-21 (2001).
Benedetti et al., “Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats”,Biomaterials, 14:1154-160 (1993).
Benedetti et al., “Microspheres of hyaluronic acid esters—fabrication methods and In vitro hydrocortisone release”,J. Controlled Rel., 13:33-41 (1990).
Benesch and Benesch, “Thiolation of protein”,Proc Nat Acad Sci USA, 44:848-53 (1958).
Bitter and Muir, “A modified uronic acid carbozole reaction”Anal. Biochem., 4:330-34 (1962).
Boyce et al., “Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns”,Ann. Surg., 222:743-52 (1995).
Boyce et al., “Hyaluronic acid induces tumour necrosis factor-a production by human macrophages in vitro”,British J. Plast. Surg., 50:362-68 (1997).
Boyce et al., “Reduced wound contraction after grafting of full-thickness burns with a collagen and chondroitin-6-sulfate (GAG) dermal skin substitute and coverage with biobrane”,J. Burn Care Rehabil., 9:364-70 (1988).
Boyce et al., “Skin anatomy and antigen expression after burn wound closure with composite grafts of cultured skin cell and biopolymers”,Plast. Reconstr. Surg., 91:632-41 (1993).
Brown et al. (1999) Absorption of hyaluronan applied to the surface of intact skin. J. Invest. Dermatol. 113:740-746 (1999).
Brown et al., “Enhancement wound healing by topical treatment with epidermal growth factor”,New Engl. J. Med., 321:76-79 (1989).
Brun et al., “In vitro reconstructed tissues on hydroluronan-based temporary scaffolding”,J. Mater. Sci. Mater. Med., 10:683-88 (1999).
Bulpitt and Aeschllmann, “New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels”, J. Biomed. Mater. Res., 47:152-69 (1999).
Burdick and Anseth, “Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogel for bone tissue engineering”, Biomaterials, 23:4315-23 (2002).
Burns at al., “A hyaluronate based gel for the prevention of postsurgical adhesions: Evaluation in two animal species”, Fertil, Steril., 66:814-821 (1996).
Burns et al., “Preclinical evaluation of Seprafilm bioresorbable membrane”,Eur. Surg. Suppl., 577:40-48 (1997).
Burns et al., “Prevention of tissue Injury and postsurgical adhesions by precoating tissues with hyaluronic acid solutions”, J. Surg. Res., 59:644-652 (1995).
Butterworth et al., “A modification of the Ellman procedure for the estimation of protein sulfhydryl groups”,Arch Biochem. Biophys., 118:716-723 (1967).
Campoccia et al., “Quantitative assessment of the tissue response to films of hyaluronan derivatives”,Biomaterials, 17:963-975 (1996).
Campoccia et al., “Semisynthetic resorbable materials from hyaluronan esterification”,Biomaterials, 19:2101-2127 (1998).
Capozzi and Modena, “Oxidation of thiol. In: The Chemistry of the Thiol Group Part II”, Patai, S., editor. New York: Wiley, p. 785-839 (1974).
Casabona et al., “Prefabricated engineered bone flaps: an experimental model of tissue reconstruction in plastic surgery”,Plastic Reconstr. Surg., 101:577-581 (1998).
Chen and Abatangelo, “Functions of hyaluronan in wound repair”,Wound Repair Regen., 7:79-89 (1999).
Chen et al., “Photoimmobilization of sulfated hyaluronic acid for antithrombogenicity”,Bioconjugate Chem., 8:730-734 (1997).
Cheung et al., “Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors

Affiliated with

Also associated with

Rating

Crosslinked compounds and methods of making and using thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crosslinked compounds and methods of making and using thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crosslinked compounds and methods of making and using thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2653564